Finder makes money from featured partners, but editorial opinions are our own. Advertiser disclosure

How to buy icad stock

Learn how to easily invest in icad stock.

icad
NASDAQ: ICAD-USD
About 3 hours ago

$16.39

-$0.17 (-1.03%)

icad is a medical devices business based in the US. icad shares (ICAD) are listed on the NASDAQ and all prices are listed in US Dollars. icad employs 108 staff and has a trailing 12-month revenue of around $24.5 million.

How to buy icad stock

  1. Choose a stock trading platform. Use our comparison table or choose from our Top Picks below.
  2. Open an account. Provide your personal information and sign up.
  3. Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
  4. Search for the stock name – ICAD. Search for the stock by name or ticker symbol.
  5. Buy the stock. Place your order. It's that simple.

Promoted for low fees

Finder Award

SoFi Invest


  • Trade stocks for $0 and no annual fee
  • Start trading with a $0 minimum deposit
  • Get up to $1,000 in stock when you fund a new account within 30 days

Promoted for social trading

Finder Award

eToro


  • Easy to use platform with $0 stock trading & no annual fees
  • Social trading allows you to copy popular portfolios
  • FINDER EXCLUSIVE: Guaranteed $15 bonus when you sign up and deposit $100

Promoted for active trading

tastytrade


  • $0 commissions on stocks and ETFs
  • $0 closing commissions on stock and ETF options
  • Get $100 - $2,000 when you open and fund an account with $5,000 to $100,000+

icad stock price (NASDAQ: ICAD)

Use our graph to track the performance of ICAD stocks over time.

icad shares at a glance

Information last updated 2023-09-19.
Latest market close$1.85
52-week range$1.05 - $3.97
50-day moving average $2.49
200-day moving average $1.91
Wall St. target price$4.88
PE ratio N/A
Dividend yield $0 (0%)
Earnings per share (TTM) $-0.49

Buy icad stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.
1 - 7 of 7
Name Product Ratings Available asset types Minimum deposit Signup bonus
SoFi Invest
Finder Rating: 4.6 / 5: ★★★★★

Finder Award
SoFi Invest
★★★★★
Stocks, Options, ETFs, Cryptocurrency
$0
Get up to $1,000 in stock
when you fund a new account within 30 days.
Winner of Finder’s Best Low-Cost Broker award.
eToro
Finder Rating: 4.2 / 5: ★★★★★

Finder Award
EXCLUSIVE
eToro
★★★★★
Stocks, Options, ETFs, Cryptocurrency
$0
FINDER EXCLUSIVE: Get a guaranteed $15 bonus
when you sign up and deposit $100
Winner of Finder’s Best Broker for Beginners award. Not available in NY, NV, MN, TN, and HI.
tastytrade
Finder Rating: 4.1 / 5: ★★★★★
tastytrade
★★★★★
Stocks, Options, ETFs, Cryptocurrency, Futures
$0
Get $100 - $2,000
when you you open and fund an account with $5,000 to $100,000+
Highly commended for Best Derivatives Trading Platform award.
Public.com
Finder Rating: 4 / 5: ★★★★★
Public.com
★★★★★
Stocks, ETFs, Cryptocurrency, Art, Treasury Bills, Collectibles
$0
Get up to $300 in either stocks or crypto
when you use code FINDERUS to sign up and fund a new account.
2.5% fee applies to all alternative asset transactions.
Robinhood
Finder Rating: 4.2 / 5: ★★★★★
Robinhood
★★★★★
Stocks, Options, ETFs, Cryptocurrency
$0
Get a free stock
when you successfully sign up and link your bank account.
Make unlimited commission-free trades, plus earn 4.9% interest on uninvested cash in your account with Robinhood Gold.
JPMorgan Self-Directed Investing
Finder Rating: 4 / 5: ★★★★★
JPMorgan Self-Directed Investing
★★★★★
Stocks, Bonds, Options, Mutual funds, ETFs, Treasury Bills
$0
Get $50 - $700
when you open and fund an account with $5,000 - $250,000+
Pay no commissions on stocks, ETFs, mutual funds and options.
Wealthfront
Finder Rating: 4 / 5: ★★★★★
Wealthfront
★★★★★
Stocks, ETFs
$500
N/A
Wealthfront builds a free financial plan for the life you want and automate your investments at a low cost.
loading

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an adviser or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

Is it a good time to buy icad stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

icad price performance over time

Historical closes compared with the close of $1.85 from 2023-09-21

1 week (2023-09-15) -7.04%
1 month (2023-08-22) -20.26%
3 months (2023-06-22) 44.53%
6 months (2023-03-22) 48.00%
1 year (2022-09-22) -21.28%
2 years (2021-09-22) -83.04%
3 years (2020-09-22) 9.02
5 years (2018-09-21) 2.99

icad financials

Revenue TTM $24.5 million
Gross profit TTM $20.1 million
Return on assets TTM -15.92%
Return on equity TTM -35.19%
Profit margin -51.13%
Book value $1.20
Market Capitalization $46.9 million

TTM: trailing 12 months

icad share dividends

We're not expecting icad to pay a dividend over the next 12 months.

Have icad's shares ever split?

icad's shares were split on a 1:5 basis on 15 August 2012. So if you had owned 5 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your icad shares – just the quantity. However, indirectly, the new 400% higher share price could have impacted the market appetite for icad shares which in turn could have impacted icad's share price.

icad share price volatility

Over the last 12 months, icad's shares have ranged in value from as little as $1.05 up to $3.97. A popular way to gauge a stock's volatility is its "beta".

ICAD.US volatility(beta: 1.31)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while icad's is 1.314. This would suggest that icad's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

icad overview

iCAD, Inc. engages in the provision of cancer detection and therapy solutions in the United States. It operates through two segments, Cancer Detection and Cancer Therapy. The company's breast AI suite includes cancer detection, automated density assessment, and breast cancer risk assessment solutions for both 2D and 3D mammography. It offers PowerLook, a back-end architecture platform, which hosts the AI algorithm solutions and manages the communications between imaging acquisition systems, and image storage and review systems; SecondLook, a machine learning-based cancer detection algorithm that analyzes 2D full-field digital mammography images to identify and mark suspicious masses and calcifications; and PowerLook Density Assessment provides automated, consistent, and standardized breast density assessments. The company also offers ProFound AI, a deep-learning algorithm designed to detect malignant soft-tissue densities and calcifications in digital breast tomosynthesis; ProFound AI Risk, a clinical decision support tool that provides breast cancer risk estimation based on a screening mammogram; and VeraLook, a solution designed to support detection of colonic polyps in conjunction with Computed Tomography Colonography. In addition, it offers Xoft Axxent electronic brachytherapy systems for the treatment of early-stage breast, non-melanoma skin, and gynecological cancers to university research and community hospitals, cancer care clinics, veterinary facilities, and dermatology offices.

Frequently asked questions

What percentage of icad is owned by insiders or institutions?
Currently 6.07% of icad shares are held by insiders and 36.878% by institutions.
How many people work for icad?
Latest data suggests 108 work at icad.
When does the fiscal year end for icad?
icad's fiscal year ends in December.
Where is icad based?
icad's address is: 98 Spit Brook Road, Nashua, NH, United States, 03062
What is icad's ISIN number?
icad's international securities identification number is: US44934S2068
What is icad's CUSIP number?
icad's Committee on Uniform Securities Identification Procedures number is: 443209101

More guides on Finder

Ask an Expert

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Go to site